终结注射吸毒人群HIV流行:美国六城市成本效果分析
该研究用动态HIV传播模型评估美国6个城市注射吸毒人群中组合干预策略的价值。最大化健康获益的策略包含6至12种干预,ICER从94 069美元/QALY到146 256美元/QALY,可使HIV发病率降低8.1%至54.4%;理想规模覆盖下发病率降幅达16.1%至75.5%。
要点
- 针对注射吸毒者的循证干预组合可带来可观健康价值,但各城市ICER差异明显。
- 最大化健康获益的组合包含6至12种干预,HIV发病率降幅因城市而异。
- 终结注射吸毒人群HIV流行还需创新实施策略及减少社会与结构障碍的支持项目。
核心结论
- 针对注射吸毒者的循证干预可提供可观价值,但终结该人群HIV流行需创新实施策略和支持项目以减少社会与结构性的照护障碍。
研究设计与样本
- 使用针对亚特兰大、巴尔的摩、洛杉矶、迈阿密、纽约市和西雅图校准的动态HIV传播模型,评估循证干预组合在乐观或理想规模扩大下的价值。
- 估计注射吸毒人群中HIV发病率降低、质量调整生命年(QALY)和增量成本效果比(ICER),实施期10年、观察期20年,采用2018年美元。
主要发现
- 最大化健康获益的组合包含6种(亚特兰大和西雅图)至12种(迈阿密)干预,ICER从洛杉矶的94 069美元/QALY到迈阿密的146 256美元/QALY。
- 这些策略使HIV发病率在西雅图降低8.1%(可信区间[CI],2.8%-13.2%),在迈阿密降低54.4%(CI,37.6%-73.9%)。
- 理想规模覆盖下HIV发病率降幅达到16.1%-75.5%。
临床怎么用
- 临床与公共卫生决策者可参考各城市ICER和发病率降幅,优先组合实施针对注射吸毒者的循证干预。
- 实现理想覆盖需配套支持项目以减少注射吸毒者获得照护的社会与结构障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Persons who inject drugs (PWID) are at a disproportionately high risk of HIV infection. We aimed to determine the highest-valued combination implementation strategies to reduce the burden of HIV among PWID in 6 US cities. METHODS: Using a dynamic HIV transmission model calibrated for Atlanta, Baltimore, Los Angeles, Miami, New York City, and Seattle, we assessed the value of implementing combinations of evidence-based interventions at optimistic (drawn from best available evidence) or ideal (90% coverage) scale-up. We estimated reduction in HIV incidence among PWID, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs) for each city (10-year implementation; 20-year horizon; 2018 $ US). RESULTS: Combinations that maximized health benefits contained between 6 (Atlanta and Seattle) and 12 (Miami) interventions with ICER values ranging from $94 069/QALY in Los Angeles to $146 256/QALY in Miami. These strategies reduced HIV incidence by 8.1% (credible interval [CI], 2.8%-13.2%) in Seattle and 54.4% (CI, 37.6%-73.9%) in Miami. Incidence reduction reached 16.1%-75.5% at ideal scale. CONCLUSIONS: Evidence-based interventions targeted to PWID can deliver considerable value; however, ending the HIV epidemic among PWID will require innovative implementation strategies and supporting programs to reduce social and structural barriers to care.
引用
- Krebs E, Zang X, Enns B, et al. Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities. J Infect Dis. 2020. PMID: 32877548. doi:10.1093/infdis/jiaa130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。